Delisting riskPopularity #3,970
GT Biopharma (GTBP)
Developer of natural-killer-cell engagers for cancer and autoimmune disease.
$6.96
After hours−0.14 (−1.97%)
At close$7.10(−1.11%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 4.66% | 84.1K shares | |
|---|---|---|---|
| 58 holders · as of Jun 30, 2026 | |||
| Strategic holders | 9.99% | 180.3K shares | |
| 1 holder · as of Sep 15, 2026 | |||
| Other | 85.35% | 1.54M shares | |
| remainder | |||
1.80M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (1.80M in the company's Sep 23, 2026 report, 1.26M elsewhere); stakes use the report.
13F, as of Jun 30, 2026
58 holders · 2.10M shares · 24 new positions · 31 increased · 8 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 376.4K | 20.86% | −75.5K | Aug 13, 2026 |
| Geode Capital Management, LLC | 266.8K | 14.79% | −27.7K | Aug 12, 2026 |
| Vanguard Fiduciary Trust Co | 225.9K | 12.52% | 0 | Aug 13, 2026 |
| HRT Financial LP | 107.1K | 5.94% | +107.1K | Aug 14, 2026 |
| Everhart Financial Group, Inc. | 100.0K | 5.54% | +100.0Knew | Jul 9, 2026 |
| SRS Capital Advisors, Inc. | 93.6K | 5.19% | 0 | Aug 10, 2026 |
| Opal Wealth Advisors, LLC | 81.8K | 4.53% | +81.8Knew | Jul 20, 2026 |
| Northern Trust Corp | 75.5K | 4.18% | +75.5Knew | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| RainForest Partners, LLC | 9.99% | 180.3K | 13G | Sep 15, 2026 |
| Five Narrow Lane LP | 9.99% | 13G | May 14, 2025 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.